Hexoquinase

Hexoquinase is not a widely recognized enzyme name in standard biochemistry references. In most contexts the term appears to be a misspelling or informal reference to hexokinase, the enzyme family that phosphorylates hexose sugars in glycolysis.

The canonical reaction catalyzed by hexokinases is the transfer of a phosphate from ATP to a hexose sugar, yielding a hexose-6-phosphate and ADP. Glucose is the primary substrate in most tissues, producing glucose-6-phosphate that enters glycolysis, the pentose phosphate pathway, or glycogen synthesis. Some hexose substrates can be phosphorylated to a lesser extent, reflecting differences in substrate specificity among hexokinase isoforms.

In mammals, the hexokinase family includes several isozymes: HK1, HK2, HK3 and HK4 (glucokinase). HK1–HK3 are widely expressed and generally inhibited by their product glucose-6-phosphate; they function in the cytosol and have relatively high affinity for glucose. Glucokinase, with a higher Km for glucose and not inhibited by G6P, is primarily expressed in liver and pancreatic beta cells and acts as a glucose sensor to regulate blood glucose levels. The enzymes operate through an induced-fit mechanism and require Mg2+ as a cofactor; their activity reflects cellular metabolic demand and glucose availability.

Physiologically, hexokinases provide phosphorylated glucose for glycolysis and other pathways and help trap glucose within cells. In pathology, altered hexokinase expression is observed in cancer and metabolic disorders, making the enzyme a focus of research and therapeutic interest. If used in literature, hexoquinase most likely refers to hexokinase, or to a fictional/alternative term, rather than to a distinct, separate enzyme.